We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+3.11%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$292M
AUM Growth
+$17.7M
Cap. Flow
+$28.8M
Cap. Flow %
9.86%
Top 10 Hldgs %
37.34%
Holding
390
New
29
Increased
31
Reduced
89
Closed
29

Sector Composition

Rank Sector Weight
1 Technology 23.85%
2 Miscellaneous 16.47%
3 Healthcare 13.08%
4 Consumer Staples 11.79%
5 Financials 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBIN icon
51
Fortune Brands Innovations
FBIN
$5.43B
$1.18M 0.4%
25,710
-1,404
-5% -$66.3K
PFE icon
52
Pfizer
PFE
$159B
$1.15M 0.39%
37,313
+8,360
+29% +$255K
MAR icon
53
Marriott International
MAR
$91.5B
$1.06M 0.36%
12,865
-300
-2% -$22.6K
PSK icon
54
State Street SPDR ICE Preferred Securities ETF
PSK
$678M
$1.05M 0.36%
+25,025
New +$1.09M
OXY icon
55
Occidental Petroleum
OXY
$59.1B
$1.04M 0.35%
14,540
-500
-3% -$35.5K
PYPL icon
56
PayPal
PYPL
$45.9B
$1.03M 0.35%
26,080
+13,600
+109% +$547K
EMLC icon
57
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
$1.02M 0.35%
28,850
+6,875
+31% +$248K
BNY
58
Bank of New York Mellon
BNY
$110B
$927K 0.32%
19,556
GOOG icon
59
Alphabet (Google) Class C
GOOG
$4.19T
$920K 0.32%
23,620
+1,740
+8% +$67.8K
BPFHP
60
DELISTED
Boston Private Financial Holdings, Inc.
BPFHP
$910K 0.31%
36,268
+3,050
+9% +$78K
GNTX icon
61
Gentex
GNTX
$4.78B
$849K 0.29%
43,100
-66,575
-61% -$1.21M
MMP
62
DELISTED
Magellan Midstream Partners, L.P.
MMP
$823K 0.28%
10,888
HP icon
63
Helmerich & Payne
HP
$4.25B
$798K 0.27%
10,315
AMGN icon
64
Amgen
AMGN
$234B
$777K 0.27%
5,314
-250
-4% -$37.6K
NVO
65
Novo Nordisk
NVO
$202B
$762K 0.26%
42,500
-3,000
-7% -$54.4K
DUK icon
66
Duke Energy
DUK
$93.8B
$693K 0.24%
8,932
MSM icon
67
MSC Industrial Direct
MSM
$6.66B
$687K 0.24%
7,435
RMD icon
68
ResMed
RMD
$34.7B
$682K 0.23%
10,990
+5,600
+104% +$343K
FLO icon
69
Flowers Foods
FLO
$1.51B
$672K 0.23%
33,651
VRTX icon
70
Vertex Pharmaceuticals
VRTX
$137B
$665K 0.23%
9,025
-600
-6% -$48.8K
EW icon
71
Edwards Lifesciences
EW
$52B
$616K 0.21%
+19,725
New +$639K
EMB icon
72
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$614K 0.21%
5,570
-350
-6% -$39.3K
BAC icon
73
Bank of America
BAC
$436B
$604K 0.21%
27,324
XBI icon
74
State Street SPDR S&P Biotech ETF
XBI
$11.3B
$592K 0.2%
9,995
-16,020
-62% -$989K
KMI icon
75
Kinder Morgan
KMI
$70.3B
$552K 0.19%
26,639
-3,928
-13% -$83K

Similar funds

American Research & Management Company's Q4 2016 Portfolio in Review

As of Q4 2016, American Research & Management Company held 390 positions worth $292M, up 6.4% from $274M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

American Research & Management Company deployed $28.8M of net new capital in Q4 2016, opening 29 new positions and adding to 31 existing holdings. Its largest new stake was Waters Corp: 47,690 shares worth $6.41M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was Gentex, an estimated $1.21M trimmed.

  • American Research & Management Company's largest Q4 2016 buy was Waters Corp: 47,690 shares worth $6.41M.
  • American Research & Management Company added most to KeyCorp in Q4 2016, an estimated $1.16M increase.
  • American Research & Management Company's biggest Q4 2016 reduction was Gentex, cutting an estimated $1.21M.
  • American Research & Management Company fully exited PIEDMONT NATURAL GAS CO INC(NC in Q4 2016, selling an estimated $105K.
  • American Research & Management Company's ten largest holdings make up 37% of its $292M portfolio in Q4 2016.
  • American Research & Management Company opened 29 new positions and closed 29 in Q4 2016.
  • American Research & Management Company's portfolio value rose 6.4% quarter-over-quarter to $292M.

Based on American Research & Management Company's 13F filing for Q4 2016, filed 31 Jan 2017.